Free Trial
NASDAQ:HSDT

Helius Medical Technologies (HSDT) Stock Price, News & Analysis

Helius Medical Technologies logo
$8.05 -0.70 (-8.00%)
Closing price 04:00 PM Eastern
Extended Trading
$8.18 +0.13 (+1.61%)
As of 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Helius Medical Technologies Stock (NASDAQ:HSDT)

Key Stats

Today's Range
$8.00
$8.78
50-Day Range
$8.43
$240.50
52-Week Range
$8.04
$1,200.00
Volume
151,611 shs
Average Volume
37,344 shs
Market Capitalization
$80.50 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Helius Medical Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

HSDT MarketRank™: 

Helius Medical Technologies scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Helius Medical Technologies is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Helius Medical Technologies is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Helius Medical Technologies has a P/B Ratio of 0.04. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Helius Medical Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    92.22% of the float of Helius Medical Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Helius Medical Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Helius Medical Technologies has recently decreased by 99.65%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Helius Medical Technologies does not currently pay a dividend.

  • Dividend Growth

    Helius Medical Technologies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    92.22% of the float of Helius Medical Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Helius Medical Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Helius Medical Technologies has recently decreased by 99.65%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Helius Medical Technologies has a news sentiment score of -0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Helius Medical Technologies this week, compared to 1 article on an average week.
  • MarketBeat Follows

    2 people have added Helius Medical Technologies to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Helius Medical Technologies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.90% of the stock of Helius Medical Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 18.63% of the stock of Helius Medical Technologies is held by institutions.

  • Read more about Helius Medical Technologies' insider trading history.
Receive HSDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helius Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

HSDT Stock News Headlines

Helius Medical Technologies, Inc. (HSDT) - Yahoo Finance
BofA: Is this the next SpaceX?
Everyone is focusing on AI stocks... Yet little-known "space stocks" are rocketing to record highs with gains of 588% - 3,710%! One new space stock that I call "the next SpaceX" is preparing to IPO on the NASDAQ. Right now, you can grab Pre-IPO shares for less than $4.00. And my estimates suggest the valuation could soar 457% with the IPO. Get urgent details inside this free report...
See More Headlines

HSDT Stock Analysis - Frequently Asked Questions

Helius Medical Technologies' stock was trading at $502.7250 at the start of the year. Since then, HSDT stock has decreased by 98.4% and is now trading at $8.14.

Helius Medical Technologies, Inc. (NASDAQ:HSDT) issued its quarterly earnings results on Thursday, May, 1st. The company reported ($25.50) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($29.00) by $3.50. The company had revenue of $0.05 million for the quarter. Helius Medical Technologies had a negative net margin of 3,010.14% and a negative trailing twelve-month return on equity of 418.82%.

Helius Medical Technologies's stock reverse split before market open on Tuesday, July 1st 2025.The 1-50 reverse split was announced on Friday, June 27th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 30th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of HSDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Helius Medical Technologies investors own include HubSpot (HUBS), Mazor Robotics (MZOR), Netflix (NFLX), Riot Platforms (RIOT), Tesla (TSLA), Acasti Pharma (ACST) and

Company Calendar

Last Earnings
5/01/2025
Today
7/11/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:HSDT
CIK
1610853
Fax
N/A
Employees
30
Year Founded
2014

Profitability

EPS (Trailing Twelve Months)
($2,376.3201)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.74 million
Net Margins
-3,010.14%
Pretax Margin
-3,010.14%
Return on Equity
-418.82%
Return on Assets
-243.54%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.69
Quick Ratio
1.13

Sales & Book Value

Annual Sales
$520 thousand
Price / Sales
0.16
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$212.93 per share
Price / Book
0.04

Miscellaneous

Outstanding Shares
10,000
Free Float
9,000
Market Cap
$82.75 thousand
Optionable
Not Optionable
Beta
0.86

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:HSDT) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners